Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Maurizio Colecchia

Professor

Università Vita Salute San Raffaele

Italy

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Medical Imaging

40%

Immunology

30%

Cancer Biology

100%

Solid Tumor

50%

Immunohistochemistry

50%

Urology

40%

Andrology

40%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles18

Characterization of testicular embryonic-type neuroectodermal tumor and embryonic-type neuroectodermal tissue admixed with mature neuro-glial tissue using a broad immunohistochemical panel

Article Link

Year:

2024

Analysis of GATA3 and FOXA2 expression suggests that downregulation of genes involved in the maintenance of a mature yolk sac tumor phenotype may underlie sarcomatoid transformation

Article Link

Year:

2024

Preperitoneal vas deferens infiltration in high‐risk prostate cancer

Article Link

Year:

2023

Cystic Clear Cell Renal Cell Carcinoma: A Morphological and Molecular Reappraisal

Article Link

Year:

2023

Fumarate hydratase‐deficient testicular sex cord‐stromal tumour (FH‐TSCST): proposal for reclassification of a subset of Leydig cell tumours with distinct molecular and clinicopathologic features

Article Link

Year:

2023

Definition and Diagnosis of Oligometastatic Bladder Cancer: A Delphi Consensus Study Endorsed by the European Association of Urology, European Society for Radiotherapy and Oncology, and European Society of Medical Oncology Genitourinary Faculty

Article Link

Year:

2023

Anti-Müllerian hormone predicts positive sperm retrieval in men with idiopathic non-obstructive azoospermia - findings from a multi-centric cross-sectional study

Article Link

Year:

2023

Evaluation of an institutional series of low-grade oncocytic tumor (LOT) of the kidney and review of the mutational landscape of LOT

Article Link

Year:

2023

FoxA2 is a reliable marker for the diagnosis of yolk sac tumour postpubertal-type

Article Link

Year:

2023

Genomic analysis of spermatocytic tumors demonstrates recurrent molecular alterations in cases with malignant clinical behavior

Article Link

Year:

2023

Validation of a Novel Three-Dimensional (<i>3D Fusion</i>) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study

Article Link

Year:

2022

Potential of the Stromal Matricellular Protein Periostin as a Biomarker to Improve Risk Assessment in Prostate Cancer

Article Link

Year:

2022

Cabozantinib as First-line Treatment in Patients With Metastatic Collecting Duct Renal Cell Carcinoma: Results of the BONSAI Trial for the Italian Network for Research in Urologic-Oncology (Meet-URO 2 Study).

Article Link

Year:

2022

Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients with Muscle-Invasive Urothelial Bladder Cancer: 3-Year Median Follow-Up Update of PURE-01 Trial

Article Link

Year:

2022

Obituary Prof. Ondrej Hes

Article Link

Year:

2022

Total embedding of spermatic cord and hilar soft tissue in orchiectomy for seminoma: does the extensive sampling improve pathologic risk factors?

Article Link

Year:

2022

Mediastinal germ cell tumors: a narrative review of their traits and aggressiveness features.

Article Link

Year:

2022

Immunohistochemical Expression of Preferentially Expressed Antigen in Melanoma (PRAME) in the Uninvolved Background Testis, Germ Cell Neoplasia in Situ, and Germ Cell Tumors of the Testis.

Article Link

Year:

2021

Collaborators25

Barbara Avuzzi

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

paolo verderio

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

Yiying Yang

NYU Langone Health

UNITED STATES

Riccardo Valdagni

Associate Professor

University of Milan

ITALY

Daniel Berney

NHS Professor of GU pathology.

Queen Mary University of London

UNITED KINGDOM

Umberto Basso

Consultant Medical Oncologist, Full Time. Chief of Genito-Urinary Program

Istituto Oncologico Veneto IOV-IRCCS

ITALY

Giorgio Malpeli

Professor

Link Campus University

ITALY

maria rosaria raspollini

University of Florence

ITALY

Andrea Cossarizza

Full Professor of Pathology and Immunology

University of Modena and Reggio Emilia

ITALY

Valerio Gaetano Vellone

University of Genoa

ITALY

Filippo Alongi

University of Brescia

ITALY

Giovanni Fucà

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

Valentina Doldi

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

Antonio De Leo

University of Bologna

ITALY

Giovanni Centonze

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

Cristina Marenghi

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

Paolo Gandellini

Associate Professor

University of Milan

ITALY

Melissa Bersanelli

Adjunct Professor in Medical Oncology

University of Parma

ITALY

Aristotelis Bamias

GREECE

Silva Ljevar

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

Stefano Gobbo

Professore Associato

University of Ferrara

ITALY

Holger Moch

Professor

University of Zurich

SWITZERLAND

Andres Martin Acosta

UNITED STATES

Luisa Barzon

Associate Professor

University of Padova

ITALY

Nadia Zaffaroni

Head of Research Unit (Molecular Pharmacology)

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

How do I reach out?

Meet Kite AI